Anzeige
Erschienen in:
19.08.2020 | Ultrasound
Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients
Erschienen in: European Radiology | Ausgabe 2/2021
Einloggen, um Zugang zu erhaltenAbstract
Objectives
The purpose of this study was to evaluate the long-term efficacy and safety of radiofrequency ablation (RFA) for low-risk papillary thyroid microcarcinoma (PTMC) in a large population.
Methods
From June 2014 to December 2017, 414 patients (323 females, 91 males, mean age 43.56 ± 9.79 years, range 18–73 years) with unifocal low-risk PTMC confirmed by core-needle biopsy (CNB) were treated by RFA. Patients were followed up at 1, 3, 6, and 12 months and every 6–12 months thereafter by ultrasound and contrast-enhanced ultrasound (CEUS). The volume and the volume reduction ratio (VRR) were calculated. Recurrence and lymph node or distant metastasis were evaluated.
Results
The mean initial volume was 92.74 ± 83.43 mm3 (range 4.19–490.07 mm3), which decreased significantly to 1.37 ± 7.94 mm3 (range 0–67.97 mm3) at a mean follow-up time of 42.15 ± 11.88 months (range 24–69 months) with a mean VRR of 98.81 ± 6.41% (range 50–100%). No life-threatening or delayed complications occurred. After RFA, 366 tumors (88.41%) completely disappeared. The overall incidence of local tumor progression rate was 3.62%. Among them, one patient (0.24%) was diagnosed to have residual cancer by CNB and underwent additional RFA. Four patients (0.97%) developed metastatic lymph node, and 10 patients (2.42%) had recurrent PTMC. A total of 13 patients underwent additional RFA, and 11 lesions completely disappeared during the follow-up.
Conclusions
RFA is an effective and safety treatment for low-risk PTMC after a long-term follow-up period for a large cohort with careful patient enrollment evaluation.
Key Points
• Radiofrequency ablation is an effective and safe alternative for low-risk PTMC.
• The overall incidence of local tumor progression rate was low.
• No life-threatening or delayed complications occurred.